Home › NDC Lookup › Labelers › Bsp Pharmaceuticals S.p.a.

Bsp Pharmaceuticals S.p.a. NDCs and Package Codes

This page lists NDC package records associated with labeler code 43624 (Bsp Pharmaceuticals S.p.a.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

39
Package NDCs
39
Products
39
Active listings
0
Discontinued
24
Ingredients
0
Therapeutic classes
6
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
Multiple-Dose Tirzepatide Injectio... 6
tirzepatide 6
Pemetrexed disodium heptahydrate 2
Bendamustine HCI Injection 2
enfortumab vedotin-ejfv for inject... 2
pembrolizumab and berahyaluronidas... 2
telisotuzumab vedotin 2
Loncastuximab tesirine 1
sacituzumab govitecan 1
mirvetuximab soravtansine gynx 1
By dosage form
INJECTION, SOLUTION 16
INJECTION 10
INJECTION, POWDER, LYOPHILIZED, FO... 9
POWDER, FOR SOLUTION 2
TABLET, FILM COATED 1
TABLET 1

Browse records — 39 products

Drug / product Billing NDC NADAC / unit Status
Bendamustine HCI Injection 100 mg/4mL INJECTION, SOLUTION BSP · NDC 43624-0010-01 · 144 CARTON in 1 BOX (43624-010-01) / 1 VIAL, MULTI-DOSE in 1 CARTON / 4 mL in 1 VIAL, MULTI-DOSE 43624-0010-01 — On market View →
Bendamustine HCI Injection 100 mg/4mL INJECTION, SOLUTION BSP · NDC 43624-0009-01 · 144 CARTON in 1 BOX (43624-009-01) / 1 VIAL, MULTI-DOSE in 1 CARTON / 4 mL in 1 VIAL, MULTI-DOSE 43624-0009-01 — On market View →
Bortezomib 3.5mg/vial 3.5 mg/3.5mg INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION BSP · NDC 43624-0024-01 · 5 TRAY in 1 BOX (43624-024-01) / 120 VIAL, SINGLE-DOSE in 1 TRAY / 3.5 mg in 1 VIAL, SINGLE-DOSE 43624-0024-01 — On market View →
cedazuridine and decitabine 100 mg/100mg TABLET, FILM COATED BSP · NDC 43624-0022-01 · 100 mg in 1 DRUM (43624-022-01) 43624-0022-01 — On market View →
Denileukin diftitox lyo 300 mcg/vial CIT 300 ug/2mL INJECTION BSP · NDC 43624-0027-01 · 120 VIAL, SINGLE-DOSE in 1 TRAY (43624-027-01) / 2 mL in 1 VIAL, SINGLE-DOSE 43624-0027-01 — On market View →
enfortumab vedotin-ejfv for injection 20 mg/2mL INJECTION BSP · NDC 43624-0014-01 · 120 VIAL, SINGLE-DOSE in 1 TRAY (43624-014-01) / 2 mL in 1 VIAL, SINGLE-DOSE 43624-0014-01 — On market View →
enfortumab vedotin-ejfv for injection 30 mg/2mL INJECTION BSP · NDC 43624-0023-01 · 120 VIAL, SINGLE-DOSE in 1 TRAY (43624-023-01) / 2 mL in 1 VIAL, SINGLE-DOSE 43624-0023-01 — On market View →
Halaven eribulin mesylate 1 mg/2mL INJECTION BSP · NDC 43624-0002-01 · 100 TRAY in 1 BOX, UNIT-DOSE (43624-002-01) / 3 mL in 1 TRAY 43624-0002-01 — On market View →
Loncastuximab tesirine 10 mg/2.2mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION BSP · NDC 43624-0004-01 · 5 TRAY in 1 BOX (43624-004-01) / 120 VIAL in 1 TRAY / 2.2 mL in 1 VIAL 43624-0004-01 — On market View →
Mirikizumab Inj 300 mg/15 mL Vial Reform 300 mg/15mL INJECTION BSP · NDC 43624-0026-01 · 121 VIAL, SINGLE-DOSE in 1 TRAY (43624-026-01) / 15 mL in 1 VIAL, SINGLE-DOSE 43624-0026-01 — On market View →
Mirikizumab Inj 300 mg/15mL Vial 300 mg/15mL INJECTION BSP · NDC 43624-0025-01 · 121 VIAL, SINGLE-DOSE in 1 TRAY (43624-025-01) / 15 mL in 1 VIAL, SINGLE-DOSE 43624-0025-01 — On market View →
mirvetuximab soravtansine gynx 100 mg/20mL INJECTION BSP · NDC 43624-0012-01 · 4 TRAY in 1 BOX (43624-012-01) / 81 VIAL, SINGLE-DOSE in 1 TRAY / 20 mL in 1 VIAL, SINGLE-DOSE 43624-0012-01 — On market View →
Multiple-Dose Tirzepatide Injection 10 mg/.6mL INJECTION, SOLUTION BSP · NDC 43624-0036-01 · 168 VIAL in 1 TRAY (43624-036-01) / .6 mL in 1 VIAL 43624-0036-01 — On market View →
Multiple-Dose Tirzepatide Injection 12.5 mg/.6mL INJECTION, SOLUTION BSP · NDC 43624-0037-01 · 168 VIAL in 1 TRAY (43624-037-01) / .6 mL in 1 VIAL 43624-0037-01 — On market View →
Multiple-Dose Tirzepatide Injection 2.5 mg/.6mL INJECTION, SOLUTION BSP · NDC 43624-0033-01 · 168 VIAL in 1 TRAY (43624-033-01) / .6 mL in 1 VIAL 43624-0033-01 — On market View →
Multiple-Dose Tirzepatide Injection 5 mg/.6mL INJECTION, SOLUTION BSP · NDC 43624-0034-01 · 168 VIAL in 1 TRAY (43624-034-01) / .6 mL in 1 VIAL 43624-0034-01 — On market View →
Multiple-Dose Tirzepatide Injection 7.5 mg/.6mL INJECTION, SOLUTION BSP · NDC 43624-0035-01 · 168 VIAL in 1 TRAY (43624-035-01) / .6 mL in 1 VIAL 43624-0035-01 — On market View →
Multiple-Dose Tirzepatide Injection 15 mg/.6mL INJECTION, SOLUTION BSP · NDC 43624-0038-01 · 168 VIAL in 1 TRAY (43624-038-01) / .6 mL in 1 VIAL 43624-0038-01 — On market View →
Patritumab deruxtecan 100 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION BSP · NDC 43624-0021-01 · 5 TRAY in 1 BOX (43624-021-01) / 120 VIAL, SINGLE-USE in 1 TRAY / 5 mL in 1 VIAL, SINGLE-USE 43624-0021-01 — On market View →
pembrolizumab and berahyaluronidase alfa 2000 U/mL; 165 mg/mL INJECTION, SOLUTION BSP · NDC 43624-0030-01 · 221 VIAL in 1 TRAY (43624-030-01) / 2.4 mL in 1 VIAL 43624-0030-01 — On market View →
pembrolizumab and berahyaluronidase alfa 2000 U/mL; 165 mg/mL INJECTION, SOLUTION BSP · NDC 43624-0031-01 · 130 VIAL in 1 TRAY (43624-031-01) / 4.8 mL in 1 VIAL 43624-0031-01 — On market View →
Pemetrexed disodium heptahydrate 100 mg/4.2mL POWDER, FOR SOLUTION BSP · NDC 43624-0005-01 · 60 TRAY in 1 PACKAGE (43624-005-01) / 120 VIAL in 1 TRAY / 4.2 mL in 1 VIAL 43624-0005-01 — On market View →
Pemetrexed disodium heptahydrate 500 mg/20mL POWDER, FOR SOLUTION BSP · NDC 43624-0006-01 · 60 TRAY in 1 PACKAGE (43624-006-01) / 49 VIAL in 1 TRAY / 20 mL in 1 VIAL 43624-0006-01 — On market View →
Pivekimab sunirine drug product (DP) 2 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION BSP · NDC 43624-0039-01 · 5 TRAY in 1 BOX (43624-039-01) / 120 VIAL in 1 TRAY / 1 mL in 1 VIAL 43624-0039-01 — On market View →
Polatuzumab Vedotin lyophilized vials 140 mg 140 mg/7.52mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION BSP · NDC 43624-0043-01 · 3 TRAY in 1 BOX (43624-043-01) / 104 VIAL in 1 TRAY / 20 mL in 1 VIAL 43624-0043-01 — On market View →
Polatuzumab Vedotin lyophilized vials 30 mg 30 mg/1.88mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION BSP · NDC 43624-0042-01 · 3 TRAY in 1 BOX (43624-042-01) / 216 VIAL in 1 TRAY / 6 mL in 1 VIAL 43624-0042-01 — On market View →
sacituzumab govitecan 180 mg/180mg INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION BSP · NDC 43624-0008-01 · 4 TRAY in 1 BOX (43624-008-01) / 49 VIAL, SINGLE-DOSE in 1 TRAY / 180 mg in 1 VIAL, SINGLE-DOSE 43624-0008-01 — On market View →
TAR-200 21.36 mg/1 TABLET BSP · NDC 43624-0032-01 · 1 DRUM in 1 BOX (43624-032-01) / 1 BAG in 1 DRUM / 6000 TABLET in 1 BAG 43624-0032-01 — On market View →
telisotuzumab vedotin 20 mg/mL INJECTION BSP · NDC 43624-0028-01 · 5 TRAY in 1 CARTON (43624-028-01) / 120 VIAL, SINGLE-DOSE in 1 TRAY / 1 mL in 1 VIAL, SINGLE-DOSE 43624-0028-01 — On market View →
Telisotuzumab vedotin 100 mg/5mL INJECTION BSP · NDC 43624-0029-01 · 4 TRAY in 1 CARTON (43624-029-01) / 81 VIAL, SINGLE-DOSE in 1 TRAY / 5 mL in 1 VIAL, SINGLE-DOSE 43624-0029-01 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.